This is a traditional, multiauthor, large textbook covering all aspects of breast disease with over 100 contributors (mainly from the United States), whose contributions have been pulled into a very readable reference text with little overlap and a consistent style.
The text is logically broken up into sections on benign disease, clinical evaluation and diagnosis, pathology, screening, treatment and rehabilitation. I found the sections on pathology and aetiology particularly helpful, as were those chapters dealing with benign breast diseases, breast pain and pregnancy. I was also pleased to see that, in addition to the usual general chapters on the management of advanced breast cancer, chapters focusing on site-specific problems were included rather than the typical simplistic approach of considering advanced breast cancer as a single entity. An interesting section is included on rehabilitation, psychosocial issues and quality of life which, while rather targeted to an American readership, discussed many useful general issues.
Inevitably in a text of this size, production takes many months, and as a result the latest references are from 1994. For many sections this does not matter, but clearly in some areas, notably the genetics of familial breast cancer, the role of adjuvant systemic therapy in node-negative patients and new endocrine and cytotoxic agents, there has been considerable progress over the past 2 years.
Reference texts are used for two purposes: firstly, to look up information and, secondly, to obtain guidance on clinical management. I feel that the second area was not given sufficient attention, and there were very few recommendations or judgements made on the clinical use of the multiple treatment approaches now available for both early and advanced breast cancer. Of note, despite the large literature on the subject, there were no recommendations that I could find on appropriate staging investigations. A The book is based upon a meeting held in March 1995. It consists of 25 chapters plus 23 abstracts presented at the above-mentioned meeting. Each chapter is written by a different author, or authors, all experienced in the field. As reflected in the title of the book, the main focus is on the role of serotonin and the 5-HT3 receptor in the physiology of emesis. The tremendous progress made in the understanding of the physiology and the possibilities for intervention are well described, and all areas of interest are reviewed.
Both animal and human data are described. Clinical results are only mentioned in three chapters describing the general clinical approach to chemotherapy-induced emesis, the role of 5-HT3 receptor antagonists in radiotherapy-induced emesis and a discussion on the differences between the three clinically available compounds.
The variety of authors is reflected in differences in style, but most chapters are well written and the references are dated up to 1995. The two longest chapters (I and II) are written by Davis and Andrews and give a historical background and introduction to the subsequent chapters.
Chapter 25 and some of the abstracts form a bridge to the future of non-5-HT3 antiemetics by describing promising preclinical data with a selective NK1 receptor blocker.
This book is very informative for those interested in the scientific background of emesis and its implications for intervention. It represents one of the best available comprehensive sources on this topic.
For clinicians dealing with emesis in daily practice, the given information is very possibly one bridge too far.
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